{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:43:19Z","timestamp":1790390599264,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011488","name":"Health and Family Planning Committee of Pudong New Area","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011488","name":"Health and Family Planning Committee of Pudong New Area","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01530","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T11:58:45Z","timestamp":1578657525000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis"],"prefix":"10.3389","volume":"10","author":[{"given":"Zeyuan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanrong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41571-018-0095-y","article-title":"Roles of the RANKL-RANK axis in antitumour immunity - implications for therapy","volume":"15","author":"Ahern","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice","volume":"374","author":"Black","year":"2016","journal-title":"Postmenopausal Osteoporosis. N Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41413-018-0040-9","article-title":"RANKL-RANK signaling regulates osteoblast differentiation and bone formation","volume":"6","author":"Cao","year":"2018","journal-title":"Bone Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e3037","DOI":"10.1038\/cddis.2017.394","article-title":"Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrrheum.2017.22","article-title":"TNF superfamily cytokines as targets for the treatment of rheumatic diseases","volume":"13","author":"Croft","year":"2017","journal-title":"Nat. Rev. Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrendo.2015.89","article-title":"Skeletal changes through the lifespan\u2013from growth to senescence","volume":"11","author":"Farr","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/br201301003","article-title":"Osteoclasts: new insights","volume":"1","author":"Feng","year":"2013","journal-title":"Bone Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1001\/jama.2017.16952","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US Preventive Services Task Force","volume":"318","author":"Gartlehner","year":"2017","journal-title":"Jama"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-018-0019-6","article-title":"Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts","volume":"6","author":"Han","year":"2018","journal-title":"Bone Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/sj.bjp.0706000","article-title":"Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell","volume":"143","author":"Ho","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-018-1286-2","article-title":"Tetrandrine enhances the ubiquitination and degradation of Syk through an AhR-c-src-c-Cbl pathway and consequently inhibits osteoclastogenesis and bone destruction in arthritis","volume":"10","author":"Jia","year":"2019","journal-title":"Cell Death Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2013-204111","article-title":"The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments","volume":"73","author":"Karsdal","year":"2014","journal-title":"Ann. Rheumatol. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol. metab.: TEM"},{"key":"B17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrrheum.2010.133","article-title":"Novel functions for NFkappaB: inhibition of bone formation","volume":"6","author":"Krum","year":"2010","journal-title":"Nat. Rev. Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"353ra113","DOI":"10.1126\/scitranslmed.aad8949","article-title":"Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Trans. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1111\/bph.14031","article-title":"Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation","volume":"174","author":"Liu","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejmech.2018.01.022","article-title":"Structure-based development of an osteoprotegerin-like glycopeptide that blocks RANKL\/RANK interactions and reduces ovariectomy-induced bone loss in mice","volume":"145","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas","year":"2010","journal-title":"Endocr. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/bph.13045","article-title":"Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21","volume":"172","author":"Mei","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4049\/jimmunol.1002483","article-title":"The role of osteoclast-associated receptor in osteoimmunology","volume":"186","author":"Nemeth","year":"2011","journal-title":"J. Immunol.(Baltimore, Md.: 1950)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/bph.13045","article-title":"Short-term and long-term effects of osteoporosis therapies","volume":"11","author":"Reid","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bone.2017.06.020","article-title":"Postmenopausal osteoporosis in rheumatoid arthritis: the estrogen deficiency-immune mechanisms link","volume":"103","author":"Sapir-Koren","year":"2017","journal-title":"Bone"},{"key":"B27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","article-title":"Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals","volume":"132","author":"Shinohara","year":"2008","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1242\/bio.025460","article-title":"Symmetrical retrograde actin flow in the actin fusion structure is involved in osteoclast fusion","volume":"6","author":"Takito","year":"2017","journal-title":"Biol. Open"},{"key":"B31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tips.2004.01.009","article-title":"Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation","volume":"25","author":"Wang","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrendo.2014.55","article-title":"Insights from the global longitudinal study of osteoporosis in women (GLOW)","volume":"10","author":"Watts","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrendo.2016.91","article-title":"Physiological and pathophysiological bone turnover - role of the immune system","volume":"12","author":"Weitzmann","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13046-018-0779-2","article-title":"Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy","volume":"37","author":"Yu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T11:58:47Z","timestamp":1578657527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":34,"alternative-id":["10.3389\/fphar.2019.01530"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01530","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]},"article-number":"1530"}}